Intravenous carboplatin for recurrent gliomas. A dose-escalating phase II trial.
about
Phase II study of carboplatin and erlotinib (Tarceva, OSI-774) in patients with recurrent glioblastoma.Phase II study of carboplatin, irinotecan, and bevacizumab for bevacizumab naïve, recurrent glioblastoma.An evaluation of the safety and feasibility of convection-enhanced delivery of carboplatin into the white matter as a potential treatment for high-grade glioma.Safety and efficacy of erlotinib in first-relapse glioblastoma: a phase II open-label study.Platinum-based chemotherapy in recurrent high-grade glioma patients: retrospective study.Phase 2 study of carboplatin, irinotecan, and bevacizumab for recurrent glioblastoma after progression on bevacizumab therapy.Chemotherapy in the treatment of malignant gliomas.Recurrent glioblastoma multiforme: advances in treatment and promising drug candidates.The role of cytotoxic chemotherapy in the management of progressive glioblastoma : a systematic review and evidence-based clinical practice guideline.State of the art and perspectives in the treatment of glioblastoma.Treating recurrent glioblastoma: an update.Evaluation of nanoparticle delivered cisplatin in beagles.Blood-brain barrier, cytotoxic chemotherapies and glioblastoma.Enhanced brain distribution of carboplatin in a primate model after blood-brain barrier disruption using an implantable ultrasound device.
P2860
Q33346827-6DD6211C-72DD-48A0-BD48-2E3747FBAC7BQ33397569-45E588A5-BF82-4AD9-A804-31DC35C4EA37Q34220547-4F368183-1860-4E6E-8025-CE9F76D0F3C4Q34480633-AAE7B945-D66D-4297-94B2-ED781606D5E2Q34746203-8BB01BD9-B5E3-47FA-AE83-173753107A02Q35172814-4E55EF18-59AF-4713-A825-AD232FEB7E61Q36499238-FA05004B-F1F0-4648-860C-E56C6E3A7247Q36668246-346892B8-7B18-4D7E-8F91-D058E84DF265Q38205133-E11A41ED-3F1D-4B15-BA73-2528140CE42CQ38233067-1CF409B1-325B-4857-A74A-68D7E7BE8E74Q38376610-7C072FC8-63A1-44B5-978C-A7B1E3574378Q38847283-8E2CA8C9-1498-43AF-A9A1-A9ACD27880BAQ38867048-C53A3160-D6EC-4ACF-BA69-2B2AF548AB09Q51615250-C014BC9A-C536-4C47-9771-A3287EF86FCE
P2860
Intravenous carboplatin for recurrent gliomas. A dose-escalating phase II trial.
description
1996 nî lūn-bûn
@nan
1996 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Intravenous carboplatin for recurrent gliomas. A dose-escalating phase II trial.
@ast
Intravenous carboplatin for recurrent gliomas. A dose-escalating phase II trial.
@en
type
label
Intravenous carboplatin for recurrent gliomas. A dose-escalating phase II trial.
@ast
Intravenous carboplatin for recurrent gliomas. A dose-escalating phase II trial.
@en
prefLabel
Intravenous carboplatin for recurrent gliomas. A dose-escalating phase II trial.
@ast
Intravenous carboplatin for recurrent gliomas. A dose-escalating phase II trial.
@en
P2093
P1476
Intravenous carboplatin for recurrent gliomas. A dose-escalating phase II trial.
@en
P2093
Chandler KL
Warnick RE
P304
P356
10.1097/00000421-199612000-00016
P577
1996-12-01T00:00:00Z